Description of the medicine: Sulperazone (Sulperazonum)
A drug containing cefoperazone in combination with sulbactam. Sulbactam is a β-lactamase inhibitor. Due to cefoperazone, stability, antibacterial activity and therapeutic effectiveness of the antibiotic are increased.
Indications for the use of sulperazone are the same as that of cefoperazone.
4-6 g per day are administered intravenously (in 2 divided doses), followed by a dose reduction. The course of treatment is 7-10 or more days.
Release form: powder for injection solutions in bottles of 1 g.
Storage: List B.